Meihua International Medical Technologies Co., Ltd. (MHUAF): Total Assets

Annual figures by period end, from SEC filings.

$207.18M
As of 2025-12-31
+8.2%
3-year compound annual growth
+14.3%
5-year compound annual growth
2020-12-31: $106.05M2021-12-31: $136.86M2022-12-31: $163.58M2023-12-31: $171.92M2024-12-31: $186.24M2025-12-31: $207.18M$207.18M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$207.18M+11.2%2026-04-29, Balance as of period end
2024-12-31$186.24M+8.3%2026-04-29, Balance as of period end
2023-12-31$171.92M+5.1%2025-04-25, Balance as of period end
2022-12-31$163.58M+19.5%2024-04-24, Balance as of period end
2021-12-31$136.86M+29.1%2023-08-29, Balance as of period end
2020-12-31$106.05Mn/a2022-07-29, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$207.18M+11.2%
LENSAR, Inc. (LNSR)2025-12-31$71.43M+7.7%
CVRx, Inc. (CVRX)2025-12-31$104.79M-21.5%
AVITA Medical, Inc. (RCEL)2025-12-31$56.39M-29.3%
Apyx Medical Corp (APYX)2025-12-31$66.84M+3.1%
Carlsmed, Inc. (CARL)2025-12-31$130.12M+151.1%
Sight Sciences, Inc. (SGHT)2025-12-31$115.30M-19.3%
PRO DEX Inc (PDEX)2026-06-30$74.51M+21.8%
TELA Bio, Inc. (TELA)2025-12-31$81.42M-6.0%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗